164 related articles for article (PubMed ID: 38233757)
21. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma.
Casarin J; Bogani G; Piovano E; Falcone F; Ferrari F; Odicino F; Puppo A; Bonfiglio F; Donadello N; Pinelli C; Laganà AS; Ditto A; Malzoni M; Greggi S; Raspagliesi F; Ghezzi F
J Gynecol Oncol; 2020 Sep; 31(5):e64. PubMed ID: 32808495
[TBL] [Abstract][Full Text] [Related]
22. A clinical and pathologic comparison between stage-matched endometrial intraepithelial carcinoma and uterine serous carcinoma: is there a difference?
Hou JY; McAndrew TC; Goldberg GL; Whitney K; Shahabi S
Reprod Sci; 2014 Apr; 21(4):532-7. PubMed ID: 24023030
[TBL] [Abstract][Full Text] [Related]
23. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
[TBL] [Abstract][Full Text] [Related]
24. Comparison of clinical characteristics and prognosis in endometrial carcinoma with different pathological types: a retrospective population-based study.
Zhang G; Nie F; Zhao W; Han P; Wen J; Cheng X; Wu W; Liu Q; Sun Y; Wang Y; Liu Y; Ren F
World J Surg Oncol; 2023 Nov; 21(1):357. PubMed ID: 37986077
[TBL] [Abstract][Full Text] [Related]
25. Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
Park JY; Nam JH; Kim YT; Kim YM; Kim JH; Kim DY; Sohn I; Lee SW; Sung CO; Kim KR
Virchows Arch; 2013 Mar; 462(3):289-96. PubMed ID: 23417747
[TBL] [Abstract][Full Text] [Related]
26. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
Desai NB; Kollmeier MA; Makker V; Levine DA; Abu-Rustum NR; Alektiar KM
Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma.
Basaran D; Bruce S; Aviki EM; Mueller JJ; Broach VA; Cadoo K; Soslow RA; Alektiar KM; Abu-Rustum NR; Leitao MM
Gynecol Oncol; 2020 Jan; 156(1):70-76. PubMed ID: 31739992
[TBL] [Abstract][Full Text] [Related]
28. Is a More Comprehensive Surgery Necessary in Patients With Uterine Serous Carcinoma?
Touhami O; Trinh XB; Gregoire J; Sebastianelli A; Renaud MC; Grondin K; Plante M
Int J Gynecol Cancer; 2015 Sep; 25(7):1266-70. PubMed ID: 26067862
[TBL] [Abstract][Full Text] [Related]
29. Defining the Optimal Treatment Strategy in Patients With Uterine Serous Carcinoma.
Donkers H; Reijnen C; Galaal K; Lombaers MS; Snijders M; Kraayenbrink AA; Forrest J; Wilkinson R; Dubey S; Norris T; Bekkers R; Pijnenborg JMA; McGrane J
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e199-e205. PubMed ID: 36509615
[TBL] [Abstract][Full Text] [Related]
30. Factors prognostic of survival in advanced-stage uterine serous carcinoma.
Holman LL; Pal N; Iglesias DA; Soliman PT; Balakrishnan N; Klopp A; Broaddus RR; Fleming ND; Munsell MF; Lu KH; Westin SN
Gynecol Oncol; 2017 Jul; 146(1):27-33. PubMed ID: 28465008
[TBL] [Abstract][Full Text] [Related]
31. Survival outcomes and the prognostic significance of clinicopathological features in patients with endometrial clear cell carcinoma: a 35-year single-center retrospective study.
Ma X; Cao D; Zhou H; Wang T; Wang J; Zhang Y; Yu M; Cheng N; Peng P; Yang J; Huang H; Shen K
World J Surg Oncol; 2023 Mar; 21(1):106. PubMed ID: 36973753
[TBL] [Abstract][Full Text] [Related]
32. Oncologic safety of laparoscopic surgery for women with apparent early-stage uterine serous carcinoma: A multi-institutional retrospective cohort study.
Xu Y; Shen J; Zhang Q; He Y; Chen C; Tian Y
Int J Gynaecol Obstet; 2022 Jul; 158(1):162-171. PubMed ID: 34561857
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma.
Lee L; Howitt B; Cheng T; King M; Stawiski K; Fendler W; Chowdhury D; Matulonis U; Konstantinopoulos PA
Gynecol Oncol; 2021 Dec; 163(3):453-458. PubMed ID: 34607711
[TBL] [Abstract][Full Text] [Related]
34. Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma.
Kommoss F; Faruqi A; Gilks CB; Lamshang Leen S; Singh N; Wilkinson N; McCluggage WG
Am J Surg Pathol; 2017 Feb; 41(2):161-170. PubMed ID: 27776011
[TBL] [Abstract][Full Text] [Related]
35. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas.
Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; Haddock MG; Keeney GL; Long HJ; Dowdy SC; Podratz KC
Gynecol Oncol; 2013 Jun; 129(3):478-85. PubMed ID: 23535279
[TBL] [Abstract][Full Text] [Related]
36. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
37. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
Prueksaritanond N; Chantape W
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
[TBL] [Abstract][Full Text] [Related]
38. The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma.
Bishop EA; Lengyel ER; Yamada SD; Montag A; Temkin SM
Gynecol Oncol; 2011 Apr; 121(1):218-23. PubMed ID: 21168200
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma.
Robbins JR; Siddiqui MS; Al-Wahab Z; Laser B; Lu M; Ali-Fehmi R; Munkarah A; Elshaikh MA
Eur J Gynaecol Oncol; 2012; 33(5):449-54. PubMed ID: 23185785
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial.
Frimer M; Miller EM; Shankar V; Girda E; Mehta K; Smith HO; Kuo DYS; Goldberg GL; Einstein MH
Int J Gynecol Cancer; 2018 Nov; 28(9):1781-1788. PubMed ID: 30371562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
